Anika Therapeutics | ANIK - Nakit Ve Eşdeğer





Nakit Ve Eşdeğer Değişiklik Tarih
Abbott USD 6.8B 1.72B 2026-03
Agenus USD 18.74M 16.26M 2026-06
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Anika Therapeutics USD 38.41M 2.61M 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Heron Therapeutics USD 20.72M 5.4M 2026-06
Insmed USD 544.76M 37.42M 2026-06
Integra LifeSciences USD 214.42M 22.39M 2026-06
Intrexon USD 9.34M 1.77M 2024-06
J&J USD 20.42B 1.27B 2026-06
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Ligand Pharmaceuticals USD 1.01B 891.62M 2026-06
MacroGenics USD 113.91M 47.39M 2026-06
Merit Medical Systems USD 448.7M 39.38M 2026-06
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 6.35B 806M 2026-06
Stryker USD 3.39B 513M 2026-06
Veracyte USD 299.52M 36.38M 2026-06
Xencor USD 44.66M 30.49M 2026-06
Zimmer Biomet Holdings USD 410M 14.2M 2026-06